Zurcher Kantonalbank Zurich Cantonalbank reduced its position in HCP, Inc. (NYSE:HCP) by 61.4% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 138,573 shares of the real estate investment trust’s stock after selling 220,377 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in HCP were worth $3,614,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of HCP. Caxton Associates LP acquired a new position in HCP in the 2nd quarter valued at $495,000. The Manufacturers Life Insurance Company raised its stake in HCP by 3.3% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 492,949 shares of the real estate investment trust’s stock valued at $15,755,000 after purchasing an additional 15,623 shares during the last quarter. Nomura Holdings Inc. acquired a new position in HCP in the 2nd quarter valued at $1,342,000. Westwood Holdings Group Inc. raised its stake in HCP by 36.5% in the 2nd quarter. Westwood Holdings Group Inc. now owns 54,175 shares of the real estate investment trust’s stock valued at $1,731,000 after purchasing an additional 14,490 shares during the last quarter. Finally, Orleans Capital Management Corp LA raised its stake in HCP by 1.4% in the 2nd quarter. Orleans Capital Management Corp LA now owns 64,309 shares of the real estate investment trust’s stock valued at $2,055,000 after purchasing an additional 900 shares during the last quarter. 90.97% of the stock is owned by hedge funds and other institutional investors.
Several research analysts recently commented on the company. ValuEngine downgraded HCP from a “buy” rating to a “hold” rating in a research note on Friday, February 2nd. JPMorgan Chase & Co. upgraded HCP from a “neutral” rating to an “overweight” rating and set a $29.00 target price for the company in a report on Friday, December 15th. Zacks Investment Research upgraded HCP from a “sell” rating to a “hold” rating in a report on Thursday, November 9th. Mizuho upgraded HCP from a “neutral” rating to a “buy” rating and set a $32.00 target price for the company in a report on Thursday, November 2nd. Finally, Stifel Nicolaus dropped their target price on HCP from $30.00 to $29.00 and set a “hold” rating for the company in a report on Tuesday, November 7th. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and four have given a buy rating to the stock. HCP presently has a consensus rating of “Hold” and a consensus price target of $30.14.
The firm also recently declared a quarterly dividend, which will be paid on Friday, March 2nd. Stockholders of record on Thursday, February 15th will be issued a dividend of $0.37 per share. This represents a $1.48 dividend on an annualized basis and a dividend yield of 6.54%. The ex-dividend date of this dividend is Wednesday, February 14th. HCP’s dividend payout ratio is presently 133.33%.
ILLEGAL ACTIVITY NOTICE: This piece was originally reported by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece can be accessed at https://sportsperspectives.com/2018/02/09/zurcher-kantonalbank-zurich-cantonalbank-sells-220377-shares-of-hcp-inc-hcp.html.
HCP Company Profile
HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.
Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.